(Q79782845)

English

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients

scientific article published on 01 June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

insulin resistance

1 reference

based on heuristic

inferred from title

Ralph A. DeFronzo

5

object named as

R A DeFronzo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

M Bajaj

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Suraamornkul

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

L J Hardies

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Pratipanawatr

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 June 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

783-789

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

A family of tissue-specific resistin-like molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistin, central obesity, and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between fatty liver and hyperinsulinemia in obese Japanese children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Spatial localization in NMR spectroscopy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative studies of resistin expression and phylogenomics in human and mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802625

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.IJO.0802625

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024400%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79782845&oldid=2125092581"